Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis)

Link copied
Case Copied 29 min read

FEDERAL COURT OF AUSTRALIA

Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis) [2013] FCA 1425

Citation: Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis) [2013] FCA 1425
Parties: APOTEX PTY LIMITED (ACN 096 916 148), APOTEX INC and APOTEX RESEARCH PRIVATE LIMITED v SANOFI (FORMERLY SANOFI-AVENTIS), SANOFI-AVENTIS US LLC and BRISTOL-MYERS SQUIBB INVESTCO LLC; SANOFI (FORMERLY SANOFI-AVENTIS), SANOFI-AVENTIS US LLC and BRISTOL-MYERS SQUIBB INVESTCO LLC v APOTEX PTY LIMITED (ACN 096 916 148)
File number: NSD 1639 of 2007
Judge: NICHOLAS J
Date of judgment: 26 November 2013
Catchwords: PRACTICE AND PROCEDURE – Whether respondents should be given leave to file amended points of defence – whether proposed amendments should be refused on the basis that respondents are seeking to approbate and reprobate – whether proposed amendments adequately pleaded and particularised
Legislation: National Health Act 1953 (Cth) ss 85(2), 99ACH, 99AEB, 99AEG
Cases cited: Acohs Pty Ltd v Ucorp Pty Ltd (2012) 201 FCR 173
Apotex Pty Ltd (formerly GenRx Pty Ltd) v Sanofi-Aventis (2008) 78 IPR 485
Apotex Pty Ltd v Sanofi-Aventis (2009) 82 IPR 416
Associated Provincial Picture Houses Ltd v Wednesbury Corporation [1948] 1 KB 223
Commonwealth v Verwayen (1990) 170 CLR 394
Express Newspapers PLC v News (UK) Ltd (1990) 18 IPR 201
GenRx Pty Ltd v Sanofi-Aventis (2007) 73 IPR 502
Les Laboratoires Servier v Apotex Inc [2011] RPC 20; [2011] EWHC 730 (Pat)
Les Laboratoires Servier v Apotex Inc [2013] RPC 21; [2012] EWCA Civ 593
Lilly Icos LLC v 8PM Chemists Ltd [2010] FSR 4; [2009] EWHC 1905
Mandurah Enterprises Pty Ltd v Western Australian Planning Commission (2008) 38 WAR 276
Date of hearing: 26 November 2013
Date of publication of reasons: 23 December 2013
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 53
Counsel for the Applicants/Cross-Respondent: Mr SG Habib SC with Ms JM Beaumont
Solicitor for the Applicants/Cross-Respondent: Ashurst
Counsel for the Respondents/Cross-Claimants: Mr J Sheahan SC with Ms C Cochrane
Solicitor for the Respondents: Allens Linklaters

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 1639 of 2007

BETWEEN:

APOTEX PTY LIMITED (ACN 096 916 148)
First Applicant

APOTEX INC
Second Applicant

APOTEX RESEARCH PRIVATE LIMITED
Third Applicant

AND:

SANOFI (FORMERLY SANOFI-AVENTIS)
First Respondent

SANOFI-AVENTIS US LLC
Second Respondent

BRISTOL-MYERS SQUIBB INVESTCO LLC
Third Respondent

AND BETWEEN:

SANOFI (FORMERLY SANOFI-AVENTIS)
First Cross-Claimant

SANOFI-AVENTIS US LLC
Second Cross-Claimant

BRISTOL-MYERS SQUIBB INVESTCO LLC
Third Cross-Claimant

AND:

APOTEX PTY LIMITED (ACN 096 916 148)
Cross-Respondent

JUDGE:

NICHOLAS J

DATE OF ORDER:

26 NOVEMBER 2013

WHERE MADE:

SYDNEY

THE COURT ORDERS THAT:

1.By 17 January 2014, the respondents serve revised proposed Amended Points of Defence.

2.By 17 January 2014, the respondents provide full particulars of the matters referred to in paragraph 6(e) of the proposed Amended Points of Defence attached to their interlocutory application filed on 28 October 2013.

3.The date in Order 6 of the Orders made on 30 September 2013 be varied from 29 November 2013 to 17 December 2013.  

4.The matter be listed for Directions at…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2013] FCA 1425
Decision Date

CaseChat Overview and Summary

Apotex Pty Limited, a pharmaceutical company, sought leave from the Federal Court to amend its points of defence against Sanofi, another pharmaceutical entity. The dispute pertained to the validity of patents held by Apotex, which Sanofi alleged were infringed by certain of its products. The court was tasked with determining whether Sanofi should be permitted to file amended points of defence and whether these amendments should be refused due to an apparent contradiction in their stance.

The primary legal issue before the court was whether the respondents should be granted leave to file amended points of defence and if the proposed amendments were adequate. A further consideration was whether the respondents were attempting to approbate and reprobate by seeking to amend their defence. The court also needed to decide if the proposed amendments adequately pleaded and particularised the defences.

The court concluded that the respondents should be given leave to file amended points of defence but required that these be served by a specified date. The court emphasised that the proposed amendments must be adequately pleaded and particularised, with particular attention to certain elements referenced in the defence. The court also noted that the date for another procedural step in the case should be adjusted. The matter was to be listed for further directions, and costs were reserved for later determination.

The court's orders mandated that the respondents submit revised proposed amended points of defence by a certain date and provide full particulars of specified matters. The date for a subsequent procedural step in the case was to be varied, and the matter was scheduled for a directions hearing. Costs were reserved pending further developments in the case.

Orders

Orders of the court

1. By 17 January 2014, the respondents serve revised proposed Amended Points of Defence.

2. By 17 January 2014, the respondents provide full particulars of the matters referred to in paragraph 6(e) of the proposed Amended Points of Defence attached to their interlocutory application filed on 28 October 2013.

3. The date in Order 6 of the Orders made on 30 September 2013 be varied from 29 November 2013 to 17 December 2013.

4. The matter be listed for Directions at 9.30am on 3 February 2014.

5. Costs are reserved.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established